November newsbeat

This month's best content, all in one place:

• Tom Slater updates shareholders on the portfolio and how it is positioned to take advantage of investment opportunities in the decades ahead.
• Discover how Tempus AI 's extensive clinical and genomic data library is revolutionising cancer research, diagnostics, and treatment, creating growth potential.
• Explore key highlights from Tom Slater's discussion with The Times , where he shares insights on identifying future winners.
• Get detailed information on holdings, performance metrics, and other vital data with this month’s comprehensive factsheet.

Please note, as with any investment, your capital is at risk.

Manager Tom Slater reflects on the highlights and challenges of the past 12 months, and explains how the portfolio is well-positioned to take advantage of investment opportunities in the decades ahead.

🟠🔵 Read now

Top 30 holding Tempus AI listed on the NASDAQ this Summer. Discover the investment case behind their pioneering work on personalised healthcare, and how they are leveraging AI across cancer care, diagnostics and treatment discovery.

🟠🔵 Discover more

Over lunch with The Times, Manager Tom Slater explains the importance of extraordinary entrepreneurs in his pursuit of extreme growth: “Normal people do not change the world. You need to be unreasonable; you need to believe something that other people do not."

“When I first heard about Airbnb I thought, this is a ridiculous idea”

🟠🔵 Read more

The latest monthly factsheet for Scottish Mortgage, containing the month-end holdings, performance and discount information is now available.

🟠🔵 View the factsheet 

Enjoy this update?

Subscribe to receive monthly round-ups and new editions of Perspectives on Progress.

Please note, as with any investment, capital is at risk.

A Key Information Document for the trust is available on the Scottish Mortgage website.